This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
Welcome to our very first issue of Pharma Focus Europe On our tryst with this commendable milestone I take the opportunity to thank one and all from my editorial team my distinguished advisory board members and all the subject matter experts who have contributed with their articles
MS is used in all phases of drug development in the EU US and UK starting from preclinical pharmacokinetic PK and pharmacokineticpharmacodynamics PKPD studies through clinical trials to postmarketing commitments
Effective celltocell communication is essential for normal physiological homeostasis in multicellular organisms like humans
Biological markers or the more commonly used term Biomarkers was first heard of in the s In the coming years this term gained unprecedented popularity as myriad studies were carried out regarding the efficacy of biomarkers in the drug discovery and development process as well as in the medical diagnosis of diseases
CMET is a tyrosine kinase receptor in the MET family Normally it is expressed on the surfaces of several epithelial cells HGFSF is a common ligand of cMET receptors Cooper et al were the first to identify the MET oncogene in
Mycobacterium tuberculosis MTB which has harmed people for more than decades is the cause of the chronic lung infectious disease known as pulmonary tuberculosis TB
Wearable sensors have the potential to transform healthcare In many instances wearable sensors can pick up signs that a person is getting sick before even they realize it
The pandemic significantly accelerated the decentralisation of clinical trials and saw more data being captured offsite remotely from participants in real world settings
At the core of the transition to Industry is the drive toward robust reliable and comprehensive process automation
D printing technology also known as additive manufacturing is a digitallycontrolled technique of fabricating a product by layerwise addition of the feed material to generate complex geometric structures
The biopharmaceutical industrys reliance on the technical experience and manufacturing capacity of contract pharma continues to grow as demand for all biologic drugs surges around the world
The application of data science in the pharmaceutical industry has farreaching consequences for individuals considering a degree in this discipline Important statistical data acquired from several sources is regularly used by the pharmaceutical sector
Nanomaterials have been one of the most exciting scientific and technical innovations of the past few decades Due to their very high surface to volume ratios they exhibit properties that can differ dramatically from those for the same material in bulk
Endpoint clinical provides technology solutions to the pharmaceutical sector predominantly focused on randomization and trial supply management IRT
